In Silico Screening, In Vitro Mpro Inhibitory, and Adjunctive Therapy Value of Minocycline for the Treatment of COVID-19.

What Is Known and Objective. Novel coronavirus disease (COVID-19) is still ravaging globally since its first discovery in 2019. With the continuous emergence of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) mutant strains, therapeutic entities are still needed to be discovered. This s...

Full description

Bibliographic Details

Published in:	Journal of Clinical Pharmacy & Therapeutics pp. 1 - 13
Main Authors:	Han, Yaru, Bai, Xianxiang, Wu, Si, Luan, Xiurong, Ren, Liwen, Wang, Jinhua, She, Zhanfei, Xiao, Bin, Du, Guanhua
Format:	pictorial research tables/charts Journal Article
Published:	Wiley-Blackwell 10/9/2023
Online Access:	View this record in EBSCOhost